Myriad Genetics Inc
MYGN· Nasdaq
MYGNMyriad Genetics Inc
Source filing unavailable
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $132.97M | $107.41M | $93.93M |
| Net Income | $29.14M | $26.04M | $53.25M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR
